
Emergent BioSolutions Inc.
EBSHealthcare|Drug Manufacturers - Specialty & Generic|US
$6.06
+0.21 (+3.59%)
DCF Value
$3.57
Tangible Book / Share
$1.18
Cash / Share
$3.42
Ownership Breakdown
95.9%
Float
51.3M
Shares Outstanding
49.2M
Float Shares
Major Holders (9)
Combined: 52.1%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| BlackRock, Inc. | Holding company | 9.00% | 4,651,339 | Jul 28, 2026 | 13D/G |
| Oak Hill Advisors, L.P. | IA, PN | 6.39% | 3,613,338 | Nov 13, 2024 | 13D/G |
| Stowers Institute for Medical Research | Holding company | 5.40% | 2,770,448 | Aug 14, 2026 | 13D/G |
| American Century Companies, Inc. | Holding company | 5.40% | 2,770,448 | Aug 14, 2026 | 13D/G |
| American Century Investment Management, Inc. | Investment adviser | 5.40% | 2,770,448 | Aug 14, 2026 | 13D/G |
| Dimensional Fund Advisors LP | Investment adviser | 5.30% | 2,757,158 | Apr 9, 2026 | 13D/G |
| American Century ETF Trust | Investment company | 5.20% | 2,676,346 | Aug 14, 2026 | 13D/G |
| State Street Corporation | Holding company | 5.10% | 2,696,375 | Feb 9, 2026 | 13D/G |
| Vanguard Capital Management | Investment adviser | 4.92% | 2,540,945 | Jul 31, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 1,740,968 acquired · 324,533 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| DeGolyer Donald W | director | Oct 7, 2026 | SELL | 17,800 | $7.09 | $126.2K | Form 4 |
| Williams Paul Anthony | SVP, Products Business | Oct 1, 2026 | SELL | 3,000 | $6.53 | $19.6K | Form 4 |
| Duatschek Stephanie | EVP, CGO | Aug 5, 2026 | OTHER | 0 | — | — | Form 4 |
| Duatschek Stephanie | EVP, CGO | Aug 5, 2026 | OTHER | 6,772 | $59.07 | $400.0K | Form 4 |
| Duatschek Stephanie | EVP, CGO | Aug 5, 2026 | OTHER | 7,250 | $41.38 | $300.0K | Form 4 |
| Duatschek Stephanie | EVP, CGO | Aug 5, 2026 | OTHER | 2,308 | $11.66 | $26.9K | Form 4 |
| Duatschek Stephanie | EVP, CGO | Aug 5, 2026 | OTHER | 9,231 | $8.39 | $77.4K | Form 4 |
| Duatschek Stephanie | EVP, CGO | Aug 5, 2026 | OTHER | 125,000 | $2.33 | $291.3K | Form 4 |
| Duatschek Stephanie | EVP, CGO | Aug 5, 2026 | OTHER | 62,500 | $5.80 | $362.5K | Form 4 |
| Duatschek Stephanie | EVP, CGO | Aug 5, 2026 | OTHER | 44,834 | $8.99 | $403.1K | Form 4 |
| Williams Paul Anthony | SVP, Products Business | Jul 1, 2026 | SELL | 3,000 | $8.40 | $25.2K | Form 4 |
| Williams Paul Anthony | SVP, Products Business | Jun 8, 2026 | TAX W/H | 694 | $8.00 | $5.6K | Form 4 |
| LINDAHL RICHARD S | EVP, Chief Financial Officer | Jun 8, 2026 | TAX W/H | 3,964 | $8.00 | $31.7K | Form 4 |
| Glessner Coleen | EVP, Quality & Ethics, and CPL | Jun 8, 2026 | TAX W/H | 2,018 | $8.00 | $16.1K | Form 4 |
| Hartzel William | SVP, Bioservices | Jun 8, 2026 | TAX W/H | 1,741 | $8.00 | $13.9K | Form 4 |
| Dayal Sujata Tyagi | director | Apr 30, 2026 | AWARD | 25,344 | — | — | Form 4 |
| Dayal Sujata Tyagi | director | May 1, 2026 | SELL | 12,781 | $8.36 | $106.8K | Form 4 |
| Dayal Sujata Tyagi | director | May 1, 2026 | SELL | 980 | $8.94 | $8.8K | Form 4 |
| Dayal Sujata Tyagi | director | Apr 30, 2026 | AWARD | 11,296 | $7.99 | $90.3K | Form 4 |
| DeGolyer Donald W | director | Apr 30, 2026 | AWARD | 25,344 | — | — | Form 4 |
| DeGolyer Donald W | director | May 1, 2026 | SELL | 14,527 | $8.36 | $121.4K | Form 4 |
| DeGolyer Donald W | director | May 1, 2026 | SELL | 954 | $8.96 | $8.5K | Form 4 |
| DeGolyer Donald W | director | Apr 30, 2026 | AWARD | 11,296 | $7.99 | $90.3K | Form 4 |
| Katkin Keith | director | Apr 30, 2026 | AWARD | 25,344 | — | — | Form 4 |
| Katkin Keith | director | Apr 30, 2026 | SELL | 15,481 | $8.28 | $128.2K | Form 4 |
| Katkin Keith | director | Apr 30, 2026 | AWARD | 11,296 | $7.99 | $90.3K | Form 4 |
| White Marvin L | director | Apr 30, 2026 | AWARD | 25,344 | — | — | Form 4 |
| White Marvin L | director | Apr 30, 2026 | AWARD | 11,296 | $7.99 | $90.3K | Form 4 |
| FOWLER JOHN D JR | director | Apr 30, 2026 | AWARD | 25,344 | — | — | Form 4 |
| FOWLER JOHN D JR | director | Apr 30, 2026 | AWARD | 11,296 | $7.99 | $90.3K | Form 4 |
| Richard Ronald | director | Apr 30, 2026 | AWARD | 25,344 | — | — | Form 4 |
| Richard Ronald | director | Apr 30, 2026 | AWARD | 11,296 | $7.99 | $90.3K | Form 4 |
| Zoon Kathryn C | director | Apr 30, 2026 | AWARD | 25,344 | — | — | Form 4 |
| Zoon Kathryn C | director | May 1, 2026 | SELL | 16,145 | $8.36 | $135.0K | Form 4 |
| Zoon Kathryn C | director | May 1, 2026 | SELL | 1,057 | $8.97 | $9.5K | Form 4 |
| Zoon Kathryn C | director | Apr 30, 2026 | AWARD | 11,296 | $7.99 | $90.3K | Form 4 |
| Fowler Neal Franklin | director | Apr 30, 2026 | AWARD | 25,344 | — | — | Form 4 |
| Fowler Neal Franklin | director | Apr 30, 2026 | AWARD | 11,296 | $7.99 | $90.3K | Form 4 |
| Harsanyi Zsolt | director, officer: Chairman | Apr 30, 2026 | AWARD | 25,344 | — | — | Form 4 |
| Harsanyi Zsolt | director, officer: Chairman | Apr 30, 2026 | AWARD | 11,296 | $7.99 | $90.3K | Form 4 |
| Williams Paul Anthony | SVP, Products Business | Apr 29, 2026 | AWARD | 100,111 | — | — | Form 4 |
| Lowry Simon C | SVP, R&D, CMO | Apr 29, 2026 | AWARD | 100,111 | — | — | Form 4 |
| Glessner Coleen | EVP, Quality & Ethics, and CPL | Apr 29, 2026 | AWARD | 100,111 | — | — | Form 4 |
| LINDAHL RICHARD S | EVP, Chief Financial Officer | Apr 29, 2026 | AWARD | 162,680 | — | — | Form 4 |
| Perl Jessica | SVP, General Counsel, Corp Sec | Apr 29, 2026 | AWARD | 104,282 | — | — | Form 4 |
| Hartzel William | SVP, Bioservices | Apr 29, 2026 | AWARD | 100,111 | — | — | Form 4 |
| PAPA JOSEPH C | director, officer: President and CEO | Apr 29, 2026 | AWARD | 187,708 | — | — | Form 4 |
| Williams Paul Anthony | SVP, Products Business | Apr 1, 2026 | SELL | 4,000 | $8.44 | $33.8K | Form 4 |
| LINDAHL RICHARD S | EVP, Chief Financial Officer | May 7, 2025 | DISPOSED | 19,963 | $48.33 | $964.8K | Form 4 |
| LINDAHL RICHARD S | EVP, Chief Financial Officer | Feb 25, 2026 | DISPOSED | 20,321 | $61.01 | $1.2M | Form 4 |
| PAPA JOSEPH C | director, officer: President and CEO | Mar 3, 2026 | AWARD | 252,194 | $8.99 | $2.3M | Form 4 |
| PAPA JOSEPH C | director, officer: President and CEO | Mar 5, 2026 | TAX W/H | 37,055 | $8.44 | $312.7K | Form 4 |
| FOWLER JOHN D JR | director | Mar 3, 2026 | AWARD | 5,006 | $8.99 | $45.0K | Form 4 |
| FOWLER JOHN D JR | director | Mar 1, 2026 | OTHER | 0 | — | — | Form 4 |
| Lowry Simon C | SVP, R&D, CMO | Mar 3, 2026 | AWARD | 44,834 | $8.99 | $403.1K | Form 4 |
| Lowry Simon C | SVP, R&D, CMO | Mar 5, 2026 | TAX W/H | 10,636 | $8.44 | $89.8K | Form 4 |
| Hartzel William | SVP, Bioservices | Mar 3, 2026 | AWARD | 44,834 | $8.99 | $403.1K | Form 4 |
| Hartzel William | SVP, Bioservices | Mar 5, 2026 | TAX W/H | 9,493 | $8.44 | $80.1K | Form 4 |
| Perl Jessica | SVP, General Counsel, Corp Sec | Mar 3, 2026 | AWARD | 46,702 | $8.99 | $419.9K | Form 4 |
| Perl Jessica | SVP, General Counsel, Corp Sec | Mar 5, 2026 | TAX W/H | 6,465 | $8.44 | $54.6K | Form 4 |
| Williams Paul Anthony | SVP, Products Business | Mar 3, 2026 | AWARD | 44,834 | $8.99 | $403.1K | Form 4 |
| Williams Paul Anthony | SVP, Products Business | Mar 5, 2026 | TAX W/H | 9,397 | $8.44 | $79.3K | Form 4 |
| LINDAHL RICHARD S | EVP, Chief Financial Officer | Mar 3, 2026 | AWARD | 72,856 | $8.99 | $655.0K | Form 4 |
| LINDAHL RICHARD S | EVP, Chief Financial Officer | Mar 5, 2026 | TAX W/H | 23,650 | $8.44 | $199.6K | Form 4 |
| Glessner Coleen | EVP, Quality & Ethics, and CPL | Mar 3, 2026 | AWARD | 44,834 | $8.99 | $403.1K | Form 4 |
| Glessner Coleen | EVP, Quality & Ethics, and CPL | Mar 5, 2026 | TAX W/H | 8,199 | $8.44 | $69.2K | Form 4 |
| LINDAHL RICHARD S | EVP, Chief Financial Officer | Mar 1, 2026 | TAX W/H | 683 | $8.15 | $5.6K | Form 4 |
| Perl Jessica | SVP, General Counsel, Corp Sec | Feb 9, 2026 | TAX W/H | 918 | $11.03 | $10.1K | Form 4 |
| Glessner Coleen | EVP, Quality & Ethics, and CPL | Feb 6, 2026 | DISPOSED | 28,847 | $10.92 | $315.0K | Form 4 |
| Glessner Coleen | EVP, Quality & Ethics, and CPL | Feb 6, 2026 | TAX W/H | 2,852 | $10.92 | $31.1K | Form 4 |
| Williams Paul Anthony | SVP, Products Business | Feb 6, 2026 | DISPOSED | 8,655 | $10.92 | $94.5K | Form 4 |
| Williams Paul Anthony | SVP, Products Business | Feb 6, 2026 | TAX W/H | 1,022 | $10.92 | $11.2K | Form 4 |
| Hartzel William | SVP, Bioservices | Feb 6, 2026 | DISPOSED | 5,771 | $10.92 | $63.0K | Form 4 |
| Hartzel William | SVP, Bioservices | Feb 6, 2026 | TAX W/H | 630 | $10.92 | $6.9K | Form 4 |
| LINDAHL RICHARD S | EVP, Chief Financial Officer | Feb 6, 2026 | DISPOSED | 46,155 | $10.92 | $504.0K | Form 4 |
| LINDAHL RICHARD S | EVP, Chief Financial Officer | Feb 6, 2026 | TAX W/H | 5,642 | $10.92 | $61.6K | Form 4 |
| Lowry Simon C | SVP, R&D, CMO | Dec 14, 2025 | TAX W/H | 3,543 | $11.41 | $40.4K | Form 4 |
| Richard Ronald | director | Dec 5, 2025 | OPTION EX. | 25,748 | $5.02 | $129.3K | Form 4 |
| Richard Ronald | director | Dec 5, 2025 | TAX W/H | 10,864 | $11.90 | $129.3K | Form 4 |
| Richard Ronald | director | Dec 5, 2025 | SELL | 7,100 | $12.11 | $86.0K | Form 4 |
| Richard Ronald | director | Dec 5, 2025 | SELL | 14,884 | $11.90 | $177.1K | Form 4 |
| Richard Ronald | director | Dec 5, 2025 | OPTION EX. | 25,748 | $5.02 | $129.3K | Form 4 |
| Hartzel William | SVP, Bioservices | Nov 11, 2025 | TAX W/H | 610 | $10.88 | $6.6K | Form 4 |
| DeGolyer Donald W | director | Nov 10, 2025 | SELL | 17,801 | $10.54 | $187.6K | Form 4 |
| Dayal Sujata Tyagi | director | Nov 7, 2025 | SELL | 8,552 | $10.00 | $85.5K | Form 4 |
| LINDAHL RICHARD S | EVP, Chief Financial Officer | Oct 15, 2025 | TAX W/H | 4,995 | $9.60 | $48.0K | Form 4 |
| Glessner Coleen | EVP, Quality & Ethics, and CPL | Oct 7, 2025 | SELL | 30,608 | $10.00 | $306.1K | Form 4 |
| Zoon Kathryn C | director | Aug 15, 2025 | SELL | 7,086 | $8.87 | $62.9K | Form 4 |
| DeGolyer Donald W | director | Aug 12, 2025 | SELL | 7,844 | $8.65 | $67.8K | Form 4 |
| Hartzel William | SVP, Bioservices | Jul 11, 2025 | TAX W/H | 4,263 | $7.36 | $31.4K | Form 4 |
| Hartzel William | SVP, Bioservices | Jun 8, 2025 | TAX W/H | 1,167 | $6.63 | $7.7K | Form 4 |
| Glessner Coleen | EVP, Quality & Ethics, and CPL | Jun 8, 2025 | TAX W/H | 1,249 | $6.63 | $8.3K | Form 4 |
| Williams Paul Anthony | SVP, Products Business | Jun 8, 2025 | TAX W/H | 464 | $6.63 | $3.1K | Form 4 |
| LINDAHL RICHARD S | EVP, Chief Financial Officer | Jun 8, 2025 | TAX W/H | 2,733 | $6.63 | $18.1K | Form 4 |
| Katkin Keith | director | May 23, 2025 | SELL | 7,844 | $6.30 | $49.4K | Form 4 |
| PAPA JOSEPH C | director, officer: President and CEO | May 13, 2025 | BUY | 60,000 | $5.83 | $349.8K | Form 4 |
| Richard Ronald | director | Apr 30, 2025 | AWARD | 34,403 | — | — | Form 4 |
| Richard Ronald | director | Apr 30, 2025 | AWARD | 15,824 | $5.45 | $86.2K | Form 4 |
| White Marvin L | director | Apr 30, 2025 | AWARD | 34,403 | — | — | Form 4 |
| White Marvin L | director | Apr 30, 2025 | AWARD | 15,824 | $5.45 | $86.2K | Form 4 |
Congress & Senate Trades (13)
Stephen CohenHouse · TN09Dec 11, 2024
Josh GottheimerHouse · NJ05Nov 5, 2021
Josh GottheimerHouse · NJ05Oct 18, 2021
Josh GottheimerHouse · NJ05Sep 15, 2021
Josh GottheimerHouse · NJ05Feb 23, 2021
Gilbert CisnerosHouse · CA31Nov 24, 2020
Gilbert CisnerosHouse · CA31Jul 30, 2020
Gilbert CisnerosHouse · CA31Jun 30, 2020
Josh GottheimerHouse · NJ05Jun 26, 2020
Gilbert CisnerosHouse · CA31Jun 19, 2020
Josh GottheimerHouse · NJ05Jun 15, 2020
Stephen CohenHouse · TN09Mar 26, 2020
Stephen CohenHouse · TN09Aug 29, 2019